PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.20%
Net income growth 1.25-1.5x ZETA's 40.68%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
15.79%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3300.00%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-400.00%
Negative yoy inventory while ZETA is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-1211.11%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Some yoy increase while ZETA is negative at -192.80%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
16.81%
Operating cash flow growth at 75-90% of ZETA's 20.83%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
20.78%
CapEx growth well above ZETA's 14.14%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-16.67%
Negative yoy purchasing while ZETA stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-3900.00%
Both yoy lines negative, with ZETA at -39.54%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
2.53%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
83.55%
Issuance growth of 83.55% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.